Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: Results from population-based surveillance of candidemia in Spain

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1506-1509

  Gomez Lopez, A ^a   Alastruey Izquierdo, A ^a   Rodriguez, D ^b   Almirante, B ^b   Pahissa, A ^b   Rodriguez Tudela, J L ^a   Cuenca Estrella, M ^a   Fridkin, Scott ^c   Hajjeh, Rana ^c   Park, Benjamin ^c   Morgan, Juliette ^c   Warnock, David W ^c   Planes, Ana Maria ^b   Almela, Manel ^d   Mensa, José ^d   Reverter, Francesc Marco ^d   Soler, C Melcion ^d   Salvado, Margarita ^e   Saballs, P ^e   Gener, Amadeu ^f   Fontanals, Dionisia ^g   Xercavins, Mariona ^h   Falgueras, Lluis ⁱ   Torroella, Maria Teresa ⁱ   De Ramon, Marta ⁱ   Alonso, Carles ^j   De Otero, Jordi ^j   Sierra, Montserrat ^k   Martinez Montauti, Joaquin ^k   Morera, Maria Antonia ^l   Sanchez, Ferran ^m   Ayats, Josefina ^j   Gimenez, Montserrat ⁿ   more..

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e HOSPITAL DEL MAR   (Spain)

^f HOSPITAL SANT JOAN DE DÉU   (Spain)

^g HOSPITAL DE SABADELL   (Spain)

^h HOSPITAL MÚTUA DE TERRASSA   (Spain)

ⁱ HOSPITAL GENERAL DE CATALUNYA   (Spain)

^j HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^k HOSPITAL CLÍNIC   (Spain)

^l HOSPITAL DE TERRASSA   (Spain)

^m HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

ⁿ HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CANDIDEMIA; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; FUNGAL STRAIN; FUNGUS ISOLATION; GENE AMPLIFICATION; GENE CLUSTER; GENE SEQUENCE; MICROBIAL SENSITIVITY TEST; MOLECULAR PHYLOGENY; NONHUMAN; PARSIMONY ANALYSIS; PREVALENCE; PRIORITY JOURNAL; SPAIN; STRAIN DIFFERENCE; STRAIN IDENTIFICATION;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FUNGEMIA; HUMANS; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; PREVALENCE; SPAIN; SPECIES SPECIFICITY;

EID: 42049116513     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01595-07     Document Type: Article

References (20)

1. Almirante, B., D. Rodriguez, M. Cuenca-Estrella, M. Almela, F. Sanchez, J. Ayats, C. Alonso-Tarres, J. L. Rodriguez-Tudela, and A. Pahissa. 2006. Epidemiology, risk factors, and prognosis of Candida parapsilosis blood-stream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J. Clin. Microbiol. 44:1681-1685.
2. Almirante, B., D. Rodriguez, B. J. Park, M. Cuenca-Estrella, A. M. Planes, M. Almela, J. Mensa, F. Sanchez, J. Ayats, M. Gimenez, P. Saballs, S. K. Fridkin, J. Morgan, J. L. Rodriguez-Tudela, D. W. Warnock, and A. Pahissa. 2005. Epidemiology and predictors of mortality in cases of Candida blood-stream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J. Clin. Microbiol. 43:1829-1835.
3. Cassone, A., F. De Bernardis, E. Pontieri, G. Carruba, C. Girmenia, P. Martine, M. Fernandez-Rodriguez, G. Quindos, and J. Ponton. 1995. Biotype diversity of Candida parapsilosis and its relationship to the clinical source and experimental pathogenicity. J. Infect. Dis. 171:967-975.
4. Cuenca-Estrella, M., D. Rodriguez, B. Almirante, J. Morgan, A. M. Planes, M. Almela, J. Mensa, F. Sanchez, J. Ayats, M. Gimenez, M. Salvado, D. W. Warnock, A. Pahissa, and J. L. Rodriguez-Tudela. 2005. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. J. Antimicrob. Chemother. 55:194-199.
5. Gacser, A., W. Schafer, J. S. Nosanchuk, S. Salomon, and J. D. Nosanchuk. 2007. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet. Biol. 44:1336-1341.
6. Iida, S., T. Imai, T. Oguri, K. Okuzumi, A. Yamanaka, M. L. Moretti-Branch, K. Nishimura, and Y. Mikami. 2005. Genetic diversity of the internal transcribed spacers (ITS) and 5.8S rRNA genes among the clinical isolates of Candida parapsilosis in Brazil and Japan. Nippon Ishinkin. Gakkai Zasshi. 46:133-137.
7. Kocsube, S., M. Toth, C. Vagvolgyi, I. Doczi, M. Pesti, I. Pocsi, J. Szabo, and J. Varga. 2007. Occurrence and genetic variability of Candida parapsilosis sensu lato in Hungary. J. Med. Microbiol. 56:190-195.
8. Lin, D., L. C. Wu, M. G. Rinaldi, and P. F. Lehmann. 1995. Three distinct genotypes within Candida parapsilosis from clinical sources. J. Clin. Microbiol. 33:1815-1821.
9. Lockhart S. R., S. A. Messer, S. Tendolkar, M. A. Pfaller, and D. J. Diekema. 2007. Geographic distribution and antifungal susceptibility of newly described species Candida orthopsilosis, in comparison to the closely-related species Candida parapsilosis. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. M-555.
10. Luo, G., and T. G. Mitchell. 2002. Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J. Clin. Microbiol. 40:2860-2865.
11. Melo, A. S., A. L. Colombo, and B. A. Arthington-Skaggs. 2007. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob. Agents Chemother. 51:3081-3088.
12. Pfaller, M. A., L. Boyken, R. J. Hollis, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2005. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. J. Clin. Microbiol. 43:5425-5427.
13. Pfaller, M. A., L. Boyken, R. J. Hollis, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2006. Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods. J. Clin. Microbiol. 44:3533-3538.
14. Rodriguez-Tudela, J. L., F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, D. Denning, J. P. Donnelly, B. Dupont, W. Fegeler, C. Moore, M. Richardson, and P. E. Verweij. 2003. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeast. Clin. Microbiol. Infect. 9(8):1-8. http://www.escmid.org/Files/ E_Def_7_1_06_2002.pdf.
15. Roy, B., and S. A. Meyer. 1998. Confirmation of the distinct genotype groups within the form species Candida parapsilosis. J. Clin. Microbiol. 36:216-218.
16. Tavanti, A., A. D. Davidson, N. A. Gow, M. C. Maiden, and F. C. Odds. 2005. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J. Clin. Microbiol. 43:284-292.
17. Tavanti, A., L. A. Hensgens, E. Ghelardi, M. Campa, and S. Senesi. 2007. Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J. Clin. Microbiol. 45:1455-1462.
18. Van Asbeck, E. C., K. V. Klemons, M. Martinez, A. Tong, and D. A. Stevens. 2007. Significant differences in drug susceptibility among species in the C. parapsilosis group. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. M-534.
19. Vazquez, J. A., A. Golembieski, D. Vager, and D. Baxa. 2007. Pharmacodynamic and molecular characterization of clinical Candida parapsilosis. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. M-539.
20. White, T. J., T. Bruns, S. Lee, and J. Taylor. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p. 315-322. In M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, Inc., San Diego, CA.